| Milad Parsa Moqadam, MD | |
|
1650 Grand Concourse, Bronx, NY 10457-7697 | |
| (718) 590-1800 | |
| Not Available |
| Full Name | Milad Parsa Moqadam |
|---|---|
| Gender | Male |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 1650 Grand Concourse, Bronx, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548980709 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | P115719 (New York) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Entity Name | Peyman Younesi Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891053328 PECOS PAC ID: 4981860202 Enrollment ID: O20120731000499 |
News Archive
Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced results of operations for its fiscal 2010 fourth quarter and year ended June 30, 2010.
CRH Healthcare, a quality- and patient-focused operator of urgent care centers in Alabama and Georgia recently acquired the assets of Physicians Immediate Med, the leading urgent care and family care platform in Atlanta.
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of Actemra (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis who have used one or more disease-modifying antirheumatic drugs, such as methotrexate, that did not provide enough relief.
After months of hearings and negotiations, millions of dollars in attack ads, full-court press lobbying efforts and countless rounds of negotiations, Congress appeared to be moving toward a solution to the nation's surprise medical bill problem. Sort of.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Milad Parsa Moqadam, MD 2626 Halperin Ave, Bronx, NY 10461-2631 Ph: (718) 618-0401 | Milad Parsa Moqadam, MD 1650 Grand Concourse, Bronx, NY 10457-7697 Ph: (718) 590-1800 |
News Archive
Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced results of operations for its fiscal 2010 fourth quarter and year ended June 30, 2010.
CRH Healthcare, a quality- and patient-focused operator of urgent care centers in Alabama and Georgia recently acquired the assets of Physicians Immediate Med, the leading urgent care and family care platform in Atlanta.
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of Actemra (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis who have used one or more disease-modifying antirheumatic drugs, such as methotrexate, that did not provide enough relief.
After months of hearings and negotiations, millions of dollars in attack ads, full-court press lobbying efforts and countless rounds of negotiations, Congress appeared to be moving toward a solution to the nation's surprise medical bill problem. Sort of.
› Verified 1 days ago